...
首页> 外文期刊>Journal of Clinical Microbiology >Detection of Rifampin Resistance inMycobacterium tuberculosis in a Single Tube with Molecular Beacons
【24h】

Detection of Rifampin Resistance inMycobacterium tuberculosis in a Single Tube with Molecular Beacons

机译:用分子信标检测单管结核分枝杆菌对利福平的耐药性

获取原文
           

摘要

Current clinical assays for determining antibiotic susceptibility in Mycobacterium tuberculosis require many weeks to complete due to the slow growth of the bacilli. Here we demonstrate an extremely sensitive single-tube PCR assay that takes less than 3 h and reliably identifies rifampin-resistant M. tuberculosis in DNA extracted directly from sputum. Ninety-five percent of mutations associated with rifampin resistance occur in an 81-bp core region of the bacterial RNA polymerase gene,rpoB. All mutations that occur within this region result in rifampin resistance. The assay uses novel nucleic acid hybridization probes called molecular beacons. Five different probes are used in the same reaction, each perfectly complementary to a different target sequence within the rpoB gene of rifampin-susceptible bacilli and each labeled with a differently colored fluorophore. Together, their target sequences encompass the entire core region. The generation of all five fluorescent colors during PCR amplification indicates that rifampin-susceptible M. tuberculosis is present. The presence of any mutation in the core region prevents the binding of one of the molecular beacons, resulting in the absence of one of the five fluorescent colors. When 148 M. tuberculosis clinical isolates of known susceptibility to rifampin were tested, mutations associated with rifampin resistance were detected in 63 of the 65 rifampin-resistant isolates, and no mutations were found in any of the 83 rifampin-susceptible isolates. When DNA extracted directly from the sputum of 11 patients infected with rifampin-resistant tuberculosis was tested, mutations were detected in all of the samples. The use of this rapid assay should enable early detection and treatment of drug-resistant tuberculosis in clinical settings.
机译:由于细菌生长缓慢,目前用于确定结核分枝杆菌中抗生素敏感性的临床检测方法需要数周才能完成。在这里,我们展示了一种极其灵敏的单管PCR检测方法,耗时不到3小时,可以可靠地鉴定耐利福平的 M。直接从痰液中提取DNA的结核病。 95%的与利福平耐药相关的突变发生在细菌RNA聚合酶基因 rpoB 的81 bp核心区域。在该区域内发生的所有突变都会导致利福平耐药。该测定使用称为分子信标的新型核酸杂交探针。在同一反应中使用了五种不同的探针,每种探针与利福平敏感细菌的 rpoB 基因内的不同靶序列完美互补,并分别用不同颜色的荧光团标记。它们的靶序列一起涵盖了整个核心区域。在PCR扩增过程中所有五种荧光颜色的产生表明对利福平敏感的 M。结核病存在。核心区域中任何突变的存在都会阻止分子信标之一的结合,从而导致五种荧光色之一的缺失。当148 M。测试了对利福平敏感的结核病临床分​​离株,在65株对利福平耐药的菌株中检测到63株与利福平耐药相关的突变,在83株对利福平敏感的菌株中均未发现突变。对从11例受利福平耐药结核病感染的患者的痰液中直接提取的DNA进行测试时,在所有样品中均检测到突变。这种快速测定的使用应能够在临床环境中及早发现和治疗耐药结核病。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号